FDA Approves Merck’s KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph) Injection for Subcutaneous Use in Adults Across Most Solid Tumor Indications for KEYTRUDA® (pembrolizumab) Merck.com FDA OKs New Keytruda Shot for Cancer The New York Times FDA Approves Subcutaneous Pembrolizumab for Solid Tumors OncLive US FDA approves Merck’s injectable version of blockbuster cancer therapy Keytruda Reuters Merck wins approval of subcutaneous Keytruda, in bid to …
Read More »